Oct 7 (Reuters) - Allos Therapeutics Inc:
* Announces pricing of public offering of common stock
* Says public offering of 14 million common shares priced at $7.10 per share
* Says gross proceeds from the sale of the shares are expected to be
approximately $99.4 million
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Announces pricing of public offering of common stock
* Says public offering of 14 million common shares priced at $7.10 per share
* Says gross proceeds from the sale of the shares are expected to be
approximately $99.4 million
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.